Patents Assigned to Neoleukin Therapeutics, Inc.
  • Interleukin-2 Receptor Beta (IL-2RB) Binding Polypeptides
    Publication number: 20230340071
    Abstract: The present invention is related to, inter alia, de novo IL-2R13 binding polypeptides.
    Type: Application
    Filed: March 12, 2021
    Publication date: October 26, 2023
    Applicants: Neoleukin Therapeutics, Inc., University of Washington
    Inventors: Daniel Adriano Silva Manzano, Alfredo Quijano Rubio, Jesus Renan Vergara Gutierrez, Thomas Linsky, Jorgen Nelson